Neuromyelitis Optica Spectrum Disorders: Diagnostic Issues in Korea
Min Ju-Hong
Abstract
Min Ju-Hong
Abstract
Neuromyelitis optica (NMO) is a CNS demyelinating disorder, characterized by optic neuritis and acute myelitis. A specific autoantibody of NMO, NMO-IgG was recently detected, which resulted in the revision of the diagnostic criteria of NMO, proposed in 1999. The new diagnostic criteria emphasized the long cord lesion over 3 vertebral segments and the presence of NMO-IgG. In addition, with the positivity of NMO-IgG in longitudinal extensive myelitis, recurrent optic neuritis and autoimmune disorders, the spectrum of NMO-related disorders were broadened. The review for NMO spectrum disorders and NMO-IgG will provide a help to understand NMO, this rapidly disabling disease.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Neuromyelitis optica (NMO) is a CNS demyelinating disorder, characterized by optic neuritis and acute myelitis. A specific autoantibody of NMO, NMO-IgG was recently detected, which resulted in the revision of the diagnostic criteria of NMO, proposed in 1999. The new diagnostic criteria emphasized the long cord lesion over 3 vertebral segments and the presence of NMO-IgG. In addition, with the positivity of NMO-IgG in longitudinal extensive myelitis, recurrent optic neuritis and autoimmune disorders, the spectrum of NMO-related disorders were broadened. The review for NMO spectrum disorders and NMO-IgG will provide a help to understand NMO, this rapidly disabling disease.
Key concepts: Neuromyelitis optica, Medicine, Optic neuritis, Myelitis, Spectrum disorder, Demyelinating Disorder, Multiple sclerosis, Autoantibody